Literature DB >> 8411059

A new stable human dicentric chromosome, tdic(4;21)(p16;q22), in a woman with first trimester abortion.

F Wang1, Y Li.   

Abstract

A woman with first trimester abortion and a dicentric chromosome formed from a 4 and a 21 is described. The dicentric chromosome was stable and in the majority of cells the 21 centromere was active, while in a minority the chromosome 4 centromere was active. This shows that both centromeres were functional, but that only one functioned in any given cell. Suppression of the activity of one centromere might be the mechanism by which this dicentric chromosome achieved its stability. A dicentric formed from a chromosome 4 and a 21 has not apparently been previously reported.

Entities:  

Mesh:

Year:  1993        PMID: 8411059      PMCID: PMC1016503          DOI: 10.1136/jmg.30.8.696

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  4 in total

1.  Deletion of the centromere as a mechanism for achieving stability of a dicentric chromosome.

Authors:  A M Vianna-Morgante; C Rosenberg
Journal:  Cytogenet Cell Genet       Date:  1986

2.  Apparently isodicentric but functionally monocentric X chromosome in man.

Authors:  E Therman; G E Sarto; K Patau
Journal:  Am J Hum Genet       Date:  1974-01       Impact factor: 11.025

3.  Dicentric chromosome 13 and centromere inactivation.

Authors:  S Schwartz; C G Palmer; D D Weaver; J Priest
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  A tdic(5;15)(p31;p11) chromosome showing variation for constriction in the centromeric regions in a patient with the cri du chat syndrome.

Authors:  G W Dewald; S J Boros; M M Conroy; R J Dahl; J L Spurbeck; H A Vitek
Journal:  Cytogenet Cell Genet       Date:  1979
  4 in total
  1 in total

1.  Mixed gonadal dysgenesis in a patient with de novo tas(Y;19)(p11.3;q13.4) and 45,X mosaicism.

Authors:  Zafer Cetin; Mesut Parlak; Ozden Altiok Clark; Gungor Karaguzel; Guven Luleci; Iffet Bircan; Sibel Berker-Karauzum
Journal:  Eur J Pediatr       Date:  2013-05-08       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.